Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1254, pseudogene (RNU6-1254P) is annotated as a pseudogene related to the U6 small nuclear RNA family. Pseudogenes are non-functional genomic sequences resembling functional genes but typically lack biological activity due to sequence divergence, inactivating mutations, or incomplete structure. RNU6-1254P does not encode a functional snRNA and is not transcribed into a biologically active product. Unlike canonical U6 snRNA (such as RNU6-1), which participates in pre-mRNA splicing as part of the spliceosome, pseudogenes of the U6 family—including RNU6-1254P—are considered functionally inert and are not direct therapeutic targets or functional biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1254, pseudogene (RNU6-1254P).